A functional logistic regression model for longitudinal data J Dong University of California, Los Angeles, 2004 | | 2004 |
A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer TW Kim, A Elme, Z Kusic, JO Park, AA Udrea, SY Kim, JB Ahn, ... British journal of cancer 115 (10), 1206-1214, 2016 | 65 | 2016 |
A Two-step Estimation Approach for Logistic Varying Coefficient Modeling of Longitudinal G Li, D Senturk, J Dong | | 2015 |
A two-step estimation approach for logistic varying coefficient modeling of longitudinal data J Dong, JP Estes, G Li, D Şentürk Journal of statistical planning and inference 174, 38-51, 2016 | 5 | 2016 |
A Two-step Estimation Approach for Logistic Varying Coefficient Modeling of Longitudinal Data G Li, D Senturk, J Dong, JP Estes | | 2015 |
Assessing temporal agreement between central and local progression‐free survival times D Zeng, E Cornea, J Dong, J Pan, JG Ibrahim Statistics in medicine 34 (5), 844-858, 2015 | 1 | 2015 |
Biomarker threshold adaptive designs for survival endpoints G Diao, J Dong, D Zeng, C Ke, A Rong, JG Ibrahim Journal of biopharmaceutical statistics 28 (6), 1038-1054, 2018 | 11 | 2018 |
Celsius: a community resource for Affymetrix microarray data A Day, MRJ Carlson, J Dong, BD O'Connor, SF Nelson Genome biology 8, 1-13, 2007 | 75 | 2007 |
Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study N Udar, C Lofton-Day, J Dong, D Vavrek, AS Jung, K Meier, A Iyer, ... Journal of Cancer Research and Clinical Oncology 144, 2001-2010, 2018 | 27 | 2018 |
Disease gene characterization through large-scale co-expression analysis A Day, J Dong, VA Funari, B Harry, SP Strom, DH Cohn, SF Nelson PloS one 4 (12), e8491, 2009 | 45 | 2009 |
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age Y Lee, AC Scheck, TF Cloughesy, A Lai, J Dong, HK Farooqi, LM Liau, ... BMC medical genomics 1, 1-12, 2008 | 226 | 2008 |
Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors G Potikyan, KA France, MRJ Carlson, J Dong, SF Nelson, CT Denny Laboratory investigation 88 (12), 1291-1302, 2008 | 40 | 2008 |
Genomic landscape of meningiomas Y Lee, J Liu, S Patel, T Cloughesy, A Lai, H Farooqi, D Seligson, J Dong, ... Brain pathology 20 (4), 751-762, 2010 | 162 | 2010 |
Geometric interpretation of gene coexpression network analysis S Horvath, J Dong PLoS computational biology 4 (8), e1000117, 2008 | 884 | 2008 |
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous … LJ Wirth, S Dakhil, G Kornek, R Axelrod, D Adkins, S Pant, P O’Brien, ... Oral oncology 61, 31-40, 2016 | 24 | 2016 |
Pattern mixture models for clinical validation of biomarkers in the presence of missing data F Gao, J Dong, D Zeng, A Rong, JG Ibrahim Statistics in medicine 36 (19), 2994-3004, 2017 | 2 | 2017 |
Predictor model of root caries in older adults: reporting of evidence to the translational evidence mechanism JG Bauer, S Spackman, J Dong, N Garrett The open dentistry journal 4, 124, 2010 | 5 | 2010 |
Preferential gene expression in the limbus of the vervet monkey Z Ding, J Dong, J Liu, SX Deng Molecular vision 14, 2031, 2008 | 32 | 2008 |
Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer J Wang, G Hechmati, J Dong, GA Maglinte, B Barber, JY Douillard Current Medical Research and Opinion 32 (3), 459-465, 2016 | 7 | 2016 |
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis WB Pope, JH Chen, J Dong, MRJ Carlson, A Perlina, TF Cloughesy, ... Radiology 249 (1), 268-277, 2008 | 170 | 2008 |